Relaunch

[anonymous]

After all that what we got is an add on. Can’t wait to see the next SSP.

 

[anonymous]

After all that what we got is an add on. Can’t wait to see the next SSP.

We could show docs brand new earth shattering data and they won’t do a darn thing. Why?

Because they are going to be livid for the next 6 months come next week. Can’t wait to start sharing that feedback on my team text thread.

 

[anonymous]

After all that what we got is an add on. Can’t wait to see the next SSP.

Great. So, we are going to have the adjunctive indication added to Qelbree's label?

 

[anonymous]

For those that are wondering why Qelbree is underperforming. My marketing team just coined a new phrase: "A novel, non stimulant, first line approach." This is all over my new marketing material to providers. The problem here, virtually no commercial plans are allowing Qelbree to be prescribed "first line".

THIS DISCONNECT FROM HOME OFFICE TO THE FIELD NEEDS TO STOP!!!!!!! Honestly, why would you print a marketing piece that encourages a provider to go first line when the coverage isn't there.

This is a prime example on what you are asking us to do is confusing to Dr's which is destructive!!!!

For God sake's get your Sh+t together.

 

[anonymous]

The right thing to do was to grandfather patients into the copay card program. But it’s all about the patients right?

 

[anonymous]

The right thing to do was to grandfather patients into the copay card program. But it’s all about the patients right?

if reps thought it was tough too grow Qelbree. Just wait.